Canaccord Genuity’s KOL Event Featuring Paul Cremer, M.D, the MAVERIC Phase III trial Principal Investigator and MAVERIC Program Steering Committee Member

Past Event Cardiol Therapeutics Fireside Chat at B. Riley Securities Mind, Muscle, & Vision SummitJul 16, 2026

Past Event 2026 Annual General Meeting of ShareholdersJun 24, 2026

Past Event Cardiol Therapeutics ($CRDL): A New Approach to Treating Inflammation in Heart DiseaseMay 19, 2026